ZNF711 down-regulation promotes CISPLATIN resistance in epithelial ovarian cancer via interacting with JHDM2A and suppressing SLC31A1 expression

Cancer statistics, 2020

(2020) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

IL-6 and IL-8 are involved in JMJD2A-regulated malignancy of ovarian cancer cells

(2020) Haiyu Zhang et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

PTBP1 modulates osteosarcoma chemoresistance to cisplatin by regulating the expression of the copper transporter SLC31A1

(2020) Cheng Cheng et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Role of CC Chemokines Subfamily in the Platinum Drugs Resistance Promotion in Cancer

(2020) Maria E. Reyes et al.   Frontiers in Immunology

Clinical Significance of ZNF711 in Human Breast Cancer

(2020) Xiaoyan Li et al.   OncoTargets and Therapy

Chemoresistance in Ovarian Cancer: Prospects for New Drugs

(2020) Shivani Tendulkar et al.   Anti-Cancer Agents in Medicinal Chemistry

Upregulation of deubiquitinase USP7 by transcription factor FOXO6 promotes esophageal carcinoma progression via targeting the JMJD3/CLU axis

(2020) Nuo Li et al.   Molecular Therapy-Oncolytics

Targeting EHMT2/ G9a for cancer therapy: Progress and perspective

(2020) Suraya Jan et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Genomic profiling of platinum-resistant ovarian cancer: The road into druggable targets

(2020) Alexandre André Balieiro Anastácio da Costa et al.   SEMINARS IN CANCER BIOLOGY

Core fucosylation of copper transporter 1 plays a crucial role in cisplatin-resistance of epithelial ovarian cancer by regulating drug uptake

(2019) Xiaoxue Lv et al.   MOLECULAR CARCINOGENESIS

The roles of DNA, RNA and histone methylation in ageing and cancer

(2019) Ewa M. Michalak et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

(2018) Jianfang Liu et al.   CELL

ZFX acts as a transcriptional activator in multiple types of human tumors by binding downstream from transcription start sites at the majority of CpG island promoters

(2018) Suhn Kyong Rhie et al.   GENOME RESEARCH

The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer

(2018) Sudha Savant et al.   Cancers

FOXO1 degradation via G9a-mediated methylation promotes cell proliferation in colon cancer

(2018) Yun-Cheol Chae et al.   NUCLEIC ACIDS RESEARCH

Mutations in two large pedigrees highlight the role of ZNF711 in X-linked intellectual disability

(2017) Ilse M. van der Werf et al.   GENE

Epigenetic control via allosteric regulation of mammalian protein arginine methyltransferases

(2017) Kanishk Jain et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Epidemiology of ovarian cancer: a review

(2017) Reid Brett M. et al.   Cancer Biology & Medicine

BNIP3L in myelodysplastic syndromes and acute myeloid leukemia: impact on disease outcome and cellular response to decitabine

(2016) Mariana Lazarini et al.   HAEMATOLOGICA

BNIP3L in myelodysplastic syndromes and acute myeloid leukemia: impact on disease outcome and cellular response to decitabine

(2016) Mariana Lazarini et al.   HAEMATOLOGICA

Ovarian cancer

(2016) Ursula A. Matulonis et al.   Nature Reviews Disease Primers

miR-340 Reverses Cisplatin Resistance of Hepatocellular Carcinoma Cell Lines by Targeting Nrf2-dependent Antioxidant Pathway

(2015) Liang Shi et al.   Asian Pacific Journal of Cancer Prevention

Histone methylation modifiers in cellular signaling pathways

(2015) Hunain Alam et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Ovarian cancer standard of care: are there real alternatives?

(2015) Chiara Della Pepa et al.   Chinese Journal of Cancer

Sensitivity and resistance to treatment in the primary management of epithelial ovarian cancer

(2013) Pierre-Emmanuel Colombo et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

The mammalian copper transporters CTR1 and CTR2 and their roles in development and disease

(2013) Natalie K.Y. Wee et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Advanced ovarian cancer: what should be the standard of care?

(2013) Barbara A. Goff   Journal of Gynecologic Oncology

Comparison between copper and cisplatin transport mediated by human copper transporter 1 (hCTR1)

(2012) Xiubo Du et al.   Metallomics

EZH2 Mediates Epigenetic Silencing of Neuroblastoma Suppressor Genes CASZ1, CLU, RUNX3, and NGFR

(2011) C. Wang et al.   CANCER RESEARCH

Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper Chelator

(2010) Seiko Ishida et al.   CANCER CELL

Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer

(2010) Daniel P. Silver et al.   JOURNAL OF CLINICAL ONCOLOGY

A Functional Link between the Histone Demethylase PHF8 and the Transcription Factor ZNF711 in X-Linked Mental Retardation

(2010) Daniela Kleine-Kohlbrecher et al.   MOLECULAR CELL

A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation

(2009) Patrick S Tarpey et al.   NATURE GENETICS

Linking DNA methylation and histone modification: patterns and paradigms

(2009) Howard Cedar et al.   NATURE REVIEWS GENETICS

The Role of the Mammalian Copper Transporter 1 in the Cellular Accumulation of Platinum-Based Drugs

(2008) C. A. Larson et al.   MOLECULAR PHARMACOLOGY